Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Eye drops recalled over non-sterility: FDA

Por: Fox Business Business March 06, 2023

thumbnail

Check out what's clicking on FoxBusiness.com The (FDA) posted a warning notice that certain eye drops are being recalled worldwide — the latest in a string of recent eye drop warnings.  Pharmedica USA LLC voluntarily recalled two lots of its Purely Soothing, 15% MSM Drops due to non-sterility, according to the warning notice posted by the FDA. Use of contaminated eye drops can result in the risk of eye infections that could result in... + full article



Similar News

Pharmedica USA Recalls Purely Soothing Eye Drops

RTTNews USA Health March 06, 2023

thumbnailPhoenix, Arizona-based Pharmedica USA LLC is recalling two lots of Purely Soothing, 15 percent MSM eye drops to the consumer level due to non-sterility, the U.S. Food and Drug Administration said.The eye drop is used as an anti-inflammatory aimed to assist with symptoms of... + más

Eye drops recalled over non-sterility: FDA | Fox Business

Automakers With The Most And Fewest Recalls In 2022 | Forbes


Eye drops recalled after 55 reports of bacterial infection, 1 death in 12 states

ABC7 USA World February 04, 2023

thumbnailWednesday, federal, state and local health agencies have identified at least 55 individuals -- some in health care facilities -- across 12 states who had been infected with a strain of Pseudomonas aeruginosa that expresses bacterial enzymes, making it highly resistant to many... + más

Eye drops recalled after 55 reports of bacterial infection, 1 death in 12 states | ABC News

EzriCare recalls artificial tear drops after reports of vision loss and 1 death | CBS News


House Dems raise issues with ‘atypical’ FDA review process for Alzheimer’s drug

Politico USA Health December 30, 2022

thumbnailThe FDA’s collaboration with Biogen, the maker of a controversial Alzheimer’s drug, before it granted the product accelerated approval was “atypical” and ran afoul of the agency’s protocol for documenting interactions with drug companies, according to a joint House... + más

Alzheimer's drug approval by FDA 'rife with irregularities,' probe finds | Los Angeles Times

Probe: Alzheimer's drug approval 'rife with irregularities' | ABC News


Panel warns FDA’s beleaguered tobacco unit lacks direction

ABC News USA Health December 20, 2022

thumbnailWASHINGTON -- The lack of clear direction and priorities at the U.S. Food and Drug Administration's tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled to examine problems at the agency.A... + más

Panel warns FDA’s beleaguered tobacco unit lacks direction | Associated Press

Panel warns FDA’s beleaguered tobacco unit lacks direction | WPLG Local 10


Panel warns FDA’s beleaguered tobacco unit lacks direction

WPLG Local 10 USA Politics December 20, 2022

thumbnailWASHINGTON – The lack of clear direction and priorities at the U.S. Food and Drug Administration's tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled to examine problems at the agency.A... + más

Panel warns FDA’s beleaguered tobacco unit lacks direction | ABC News

Panel warns FDA’s beleaguered tobacco unit lacks direction | Associated Press


Panel warns FDA’s beleaguered tobacco unit lacks direction

Associated Press USA Politics December 19, 2022

thumbnailWASHINGTON (AP) — The lack of clear direction and priorities at the U.S. Food and Drug Administration’s tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled to examine problems at the agency.A... + más

Panel warns FDA’s beleaguered tobacco unit lacks direction | ABC News

Panel warns FDA’s beleaguered tobacco unit lacks direction | WPLG Local 10


ALS drug wins FDA approval despite questionable data

ABC News USA Health September 30, 2022

thumbnailWASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.Amylyx Pharmaceuticals said the Food and... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | WPLG Local 10



About iurex | Privacy Policy | Disclaimer |